The future of biology is jointly physical and digital.
We are a team of clinicians, scientists, engineers, and investors operating at the convergence of technical and commercial opportunities in the life sciences and enabling domains. Our team’s work history spans AI and data engineering, technical investing, clinical leadership at major biomedical research centers and in large-cohort IITs, scientific leadership in pharma, and executive roles in the USG.
We are based in New York City with a global operational presence.
Internal programs that move medicines into the clinic using expert and systematic evidence.
- Oncology
- Metabolism
- Immunology
- Age-Related Disease
Computational substrates for the science of biology and medicine across physical and operational length and time scales.
- Biomedical Intelligence
- Preclinical Strategy
- Clinical Trials
Scientific and operational value capture across the breadth of life sciences and biotechnology.
- Biophysical Engineering
- IP Partnerships
- Commercial Opportunities